Grand River Aseptic Manufacturing

From Wikipedia, the free encyclopedia

Grand River Aseptic Manufacturing (GRAM)
TypePrivate company
IndustryPharmaceuticals
Founded2010
HeadquartersGrand Rapids, MI, U.S.
Key people
Tom Ross, CEO[1] Nick Bykerk vice president of finance[2]
ServicesClinical and commercial sterile manufacturing
Number of employees
200(2020)[3]
Websitegrandriverasepticmfg.com

Grand River Aseptic Manufacturing (GRAM) is a clinical and commercial sterile manufacturing contractor to the pharmaceutical industry. It has lyophilization, terminal sterilization, analytical, microbiological testing services.[1]

GRAM was founded in 2010 by the Van Andel Institute and Grand Valley State University.

Arlington Capital Partners, a private equity firm in Washington, D.C. made a majority investment in GRAM in 2017.

In June 2020, GRAM finished a $60 million expansion to install a 61,500-square-foot fill-finish injectable facility on the same site to triple GRAM's manufacturing footprint to more than 100,000 square feet of production space.[4]

In 2020, BARDA and Johnson & Johnson contracted with GRAM to do fill and finish services for vaccines in response to the coronavirus pandemic.

History[]

GRAM was founded in 2010 by Van Andel Institute and Grand Valley State University.[1]

Arlington Capital Partners, a private equity firm in the Washington, D.C. made a majority investment in GRAM in 2017.[2]

Covid vaccine facility[]

In June 2020, GRAM finished a $60 million expansion to install another fill-finish injectables facility with the plan to market it to U.S. drugmakers.[4] The 61,500-square-foot facility included in that expansion tripled GRAM's manufacturing footprint to more than 100,000 square feet of production space.[4]

GRAM chose SKAN isolators, a Bausch+Ströbel filler and an IMA lyophilizer.[2][4] The facility was qualified in July 2020.[5]

In August 2020, BARDA awarded GRAM a one-year, $160 million contract to provide fill and finish services for vaccines in response to the coronavirus pandemic.[6]

In September, GRAM agreed with Janssen Pharmaceuticals, one of the companies of Johnson & Johnson, to support the manufacture of its SARS-CoV-2 vaccine candidate, including technology transfer and fill and finish manufacture.[7]

Awards[]

In 2017, 2018, 2019, and 2020 Inc. Magazine ranked GRAM as one of the Inc. 5000 fastest-growing private companies in America.[3] The company won West Michigan's Best and Brightest Companies to Work For in 2017 and 2020.[3]

References[]

  1. ^ a b c Martinez, Shandra. "Ex-Perrigo VP promoted to CEO of Grand Rapids medical supplier".
  2. ^ a b c "GRAM Continues Aggressive Expansion in Parenterals".
  3. ^ a b c "GRAM website". GRAM.
  4. ^ a b c d Blankenship, Kyle. "Johnson & Johnson signs on Michigan's Grand River to help with COVID-19 vaccine finishing work".
  5. ^ "AEC Firms Aid Virus Vaccine 'Warp Speed' Market Push".
  6. ^ "Army Taps Grand River Aseptic Manufacturing for $160M COVID-19 Vaccine Production Support Contract".
  7. ^ "Ramping Up COVID-19 Vaccine Fill and Finish Capacity".
Retrieved from ""